Pharmaceutical Commerce - June 2024

Click the title above for a link to open the Pharmaceutical Commerce June 2024 issue in an interactive PDF format.

The June issue of Pharmaceutical Commerce is headlined by a look at the influence of artificial intelligence and real-world evidence/real-world data on patient behavior and ultimately, the many complex factors that go into medicine adherence.

Beneath all the “organized chaos,” industry shows such as LogiPharma Europe spotlight the valuable opportunity offered by these events to further educate our most valuable asset: our readers.

LogiPharma Europe captured many timely topics, including the importance of next-level approaches in aligning temperature-controlled transit and visibility.

With pharmacies under pressure to lower drug-acquisition costs, a look at how digital formats can help manufacturers better manage price based on real-time data.

By marrying real-world evidence and AI, pharma stakeholders can identify new opportunities to tailor interventions in a way that is most impactful to patients—helping them overcome roadblocks in initiating and maintaining therapy.

The impact of income-based price controls in healthcare.

Companies need to alter their thinking to better prioritize patients. Here are three simple yet impactful engagement elements that could help.

New innovations that are contributing to industry environmental efforts.

If Congress doesn't act soon, it could result in more health inequities.

An analysis of the general medicine portion of the pharmacy market amid ensuing challenges.